137 participants
Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-04-30
- Start Date:
- 2013-11-13
- Completion:
- 2021-03-31
Conditions
- Anaplastic Large Cell Lymphoma, ALK-Positive
- Ann Arbor Stage II Noncutaneous Childhood Anaplastic Large Cell Lymphoma
- Ann Arbor Stage III Noncutaneous Childhood Anaplastic Large Cell Lymphoma
- Ann Arbor Stage IV Noncutaneous Childhood Anaplastic Large Cell Lymphoma
Interventions
- DRUG